Investment group SV Life Sciences said today it is rebranding to SV Health Investors.
The Boston-based company said the new moniker will “better reflect the firm’s longstanding strategy and multi-sector focus.”
The investment group said it targets early-stage opportunities in biotechnology, early-stage and revenue stage medical device opportunities and growth equity investments in later-stage businesses in healthcare and digital health fields, according to a press release.
In January, SV joined a ‘significant round of growth capital’ for medtech developer Bardy Diagnostics and its Carnation cardiac monitor and arrhythmia detection device.
The post SV Life Sciences rebrands to SV Health Investors appeared first on MassDevice.
from MassDevice http://ift.tt/2oYTcXU
Cap comentari:
Publica un comentari a l'entrada